Axios @axios
Pfizer and BioNTech aim to enroll 180 U.S. volunteers between the ages of 18 and 64 for an early-stage trial to assess the safety, efficacy and optimal dosage. https://t.co/lqVkla96vP — PolitiTweet.org
Created
Sat Nov 05 07:31:43 +0000 2022
Likes
30
Retweets
6
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Pfizer and BioNTech aim to enroll 180 U.S. volunteers between the ages of 18 and 64 for an early-stage trial to assess the safety, efficacy and optimal dosage. https://t.co/lqVkla96vP — PolitiTweet.org